The adenoma burden in heterozygote Apcfl/flSmad4+/flLgr5-CreERT2 compared to controls was statistically non-significant and does not support either Smad4 haplo-insufficiency or a dominant negative effect of Smad4fl/+. The gene discussed is SMAD4; the disease is adenoma.